TONI VOLLMER: Open Payments
NPI 1306348040 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,704 in 65 payments from 15 companies in 2025. Trend: 2023 $1,120 · 2024 $1,622 · 2025 $1,704
Food & beverage: $1,672Education: $32
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $323 |
| E.R. Squibb & Sons, L.L.C. | 10 | $291 |
| Bard Peripheral Vascular, Inc. | 2 | $260 |
| Novartis Pharmaceuticals Corporation | 12 | $202 |
| SCPHARMACEUTICALS INC. | 4 | $157 |
| Actelion Pharmaceuticals US, Inc. | 3 | $100 |
| Merck Sharp & Dohme LLC | 4 | $75 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $75 |
| Novo Nordisk Inc | 2 | $52 |
| Esperion Therapeutics, Inc. | 2 | $41 |
Products named: REPATHA, LEQVIO, CAMZYOS, RotarexS 6 F x 135 cm, FUROSCIX, ELIQUIS, Venovo, LifeVest.
Industry payments across IN — which companies pay providers there.
